stoxline Quote Chart Rank Option Currency Glossary
  
Absci Corporation (ABSI)
5.82  0.82 (16.4%)    02-14 16:00
Open: 5.09
High: 5.85
Volume: 9,911,300
  
Pre. Close: 5
Low: 5.03
Market Cap: 668(M)
Technical analysis
2025-02-14 4:46:03 PM
Short term     
Mid term     
Targets 6-month :  6.83 1-year :  7.98
Resists First :  5.84 Second :  6.83
Pivot price 4.46
Supports First :  3.87 Second :  2.65
MAs MA(5) :  5 MA(20) :  4.31
MA(100) :  3.63 MA(250) :  4.12
MACD MACD :  0.5 Signal :  0.3
%K %D K(14,3) :  97.3 D(3) :  93.8
RSI RSI(14): 76.4
52-week High :  6.71 Low :  2.45
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ ABSI ] has closed above the upper band by 6.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 83% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.85 - 5.87 5.87 - 5.89
Low: 4.98 - 5 5 - 5.02
Close: 5.78 - 5.81 5.81 - 5.85
Company Description

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Headline News

Sun, 16 Feb 2025
Needham initiates Absci shares with Buy rating on strategy - MSN

Sun, 16 Feb 2025
Absci (NASDAQ:ABSI) Trading Up 6.8% - What's Next? - MarketBeat

Sun, 16 Feb 2025
Absci Co. (NASDAQ:ABSI) Short Interest Down 10.8% in January - MarketBeat

Wed, 12 Feb 2025
Is Absci Corp. (ABSI) the Best Nasdaq Stock Under $5 to Buy? - Insider Monkey

Fri, 24 Jan 2025
Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a ‘Buy’ Rating from Needham - Yahoo Finance

Wed, 22 Jan 2025
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 115 (M)
Held by Insiders 8.594e+007 (%)
Held by Institutions 20 (%)
Shares Short 14,020 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -8.971e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 698.7 %
Return on Equity (ttm) -27.4 %
Qtrly Rev. Growth 4.21e+006 %
Gross Profit (p.s.) 58.72
Sales Per Share -22.43
EBITDA (p.s.) -2.07854e+007
Qtrly Earnings Growth -1 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -70 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.26
Price to Cash Flow 7.24
Stock Dividends
Dividend 0
Forward Dividend 2.124e+007
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android